The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
Subscribe To Our Newsletter & Stay Updated
